Bayer Says One A Day Selenium Prostate Cancer Claims Are In Fair Play
This article was originally published in The Tan Sheet
Executive Summary
Bayer asserts the prostate cancer risk reduction claims for its One A Day Men's multivitamin supplements are backed by an FDA-approved qualified health claim for selenium